NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: BASF

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BASF Partners with Acies Bio to Drive Sustainable Production of Personal and Home Care Ingredients - BASF and Acies Bio have entered into a transformative partnership to further develop a platform for fermentation technology from methanol for the production of fatty alcohols - AciesBio.com / Care-Chemicals.BASF.com
BASF Partners with Acies Bio to Drive Sustainable Production of Personal and Home Care Ingredients

 

NewswireTODAY - /newswire/ - Ludwigshafen, Rhineland-Palatinate, Germany, 2024/11/05 - BASF and Acies Bio have entered into a transformative partnership to further develop a platform for fermentation technology from methanol for the production of fatty alcohols - AciesBio.com / Care-Chemicals.BASF.com. Frankfurt (BAS)

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• Partnership on biotechnology supports the further development of fermentation technology;
• BASF to benefit from Acies Bio’s OneCarbonBio platform, the first fully flexible synthetic biology platform for efficient conversion of renewable methanol;
• Collaboration aims to develop a commercially viable technology to diversify raw materials for home and personal care products.

BASF and Acies Bio, one of Europe’s leading biotechnology companies, have entered into a transformative partnership to further develop a platform for fermentation technology from methanol for the production of fatty alcohols. Fatty alcohols are essential building blocks for several ingredients in the home and personal care markets, in particular surfactants. Acies Bio’s biotechnological expertise complements BASF’s drive for innovative solutions and contributes to shaping a more sustainable future.

Acies Bio has developed the “OneCarbonBio”, a fully flexible synthetic biology platform designed to efficiently convert renewable methanol, derived from captured CO2 emissions, into a variety of chemical raw materials. Under the terms of the partnership, BASF’s Care Chemicals division and Acies Bio will use the specialized microbes and scale up the fermentation process to produce fatty acids and derivatives serving to manufacture various chemical compounds. BASF will contribute its expertise in developing processes, providing integrated value chain solutions and accessing global markets.

Acies Bio and BASF aim to combine their strengths in a co-development effort and to build on their combined research and development expertise. For BASF, the expected benefits of the project include increased scale and flexibility, leading to a diversification of the renewable feedstock portfolio and contributing to the resilience of Care Chemicals’ global supply chain.

“Biotechnology complements our chemistry to create a more sustainable future,” said Dr. Matthias Maase, Global Director Sustainability, Care Chemicals BASF. “We are very pleased to have found the right partner in Acies Bio to further develop this innovation at an early stage. With a collaborative and interdisciplinary approach, our research scope of the partnership covers the entire chain from production strain development to large scale manufacturing. This will be of benefit to our customers in Personal Care, Home Care and I&I and Industrial Formulators worldwide.”

Dr. Gregor Kosec, Director of R&D at Acies Bio, said,“Partnering with BASF marks an important milestone, reflecting a significant recognition of Acies Bio’s R&D efforts. By combining our advanced microbial production strains and the OneCarbonBio platform with BASF’s proven process development and supply chain expertise, we are poised to bring our technologies to a global scale. This collaboration demonstrates the transformative potential of Acies Bio’s microbial innovations to drive net-zero production of specialty and industrial chemicals.”

About the Care Chemicals division at BASF

BASF’s Care Chemicals division (care-chemicals.basf.com) offers a broad range of ingredients for personal care, home care, industrial & institutional cleaning, and technical applications. We are a leading global supplier for the cosmetics industry as well as the detergents and cleaners industry, and support our customers with innovative and sustainable products, solutions and concepts. The division’s high-performance product portfolio includes surfactants, emulsifiers, polymers, emollients, chelating agents, cosmetic active ingredients and UV filters. We have production and development sites in all regions and are expanding our presence in emerging markets.

About BASF

At BASF (basf.com), we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €68.9 billion in 2023. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States.

About Acies Bio

 Acies Bio (aciesbio.com) is a leading European microbial biotechnology company that develops new bioproducts and sustainable production processes for diverse industrial sectors, including food/feed, agricultural, and industrial biotechnology. With a focus on key sustainability related challenges Acies Bio  uses its unique SmartRoute platform for rapid microbial technology development, including synthetic biology, strain engineering, directed evolution, and precision bioprocess and downstream development. Acies Bio is working with industrial partners to develop, scale and commercialize innovative bioproducts and precision fermentation technologies for global markets.

Acies Bio Media Contact: Martin Kavšček - Head of Business Development
P: +386 40 432 117 - E: martin.kavscek[.]aciesbio.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: BASF

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BASF Partners with Acies Bio to Drive Sustainable Production of Personal and Home Care Ingredients

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Acies Bio OneCarbonBio | BASF Care Chemicals
Contact: Olga Hog - BASF.com 
+49 173 3478210 olga.hog[.]basf.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any BASF securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From BASF / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

SCHOTT Pharma Unveils Innovative Nest Design for Ready-to-use Cartridges
Ipsen and Biomunex Announce Exclusive Global Licensing Agreement for First-in-class MAIT Cell Engager in Immuno-oncology
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry through Consistent Quality Assurance, On-time Delivery
Bylvay® (odevixibat) Data Shows Sustained Improvement in Severe Itch and Serum Bile Acid Levels in Patients with PFIC and ALGS
Genome BC, STEMCELL Technologies and UBC Partner to Accelerate the Ability to Develop Stem Cells
PathogenDx Applauded by Frost & Sullivan for Enabling Early and Precise UTI Diagnosis with its Microarray Detection Platform
Ipsen’s Kayfanda® (odevixibat) Approved in European Union for Cholestatic Pruritus in Alagille Syndrome, A Rare Liver Disease
STEMCELL Technologies and Axion BioSystems Partner to Streamline Culture and Analysis of Excitable Cells
Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value
BASF Declares Force Majeure for Selected Vitamin A, Vitamin E, and Carotenoid Products As Well As Selected Aroma Ingredients
Ono Pharmaceutical Co., Ltd Enters into A New Option and Research Collaboration Agreement with Monash University
Aragen Life Sciences Ltd Receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery
Ipsen’s Iqirvo® Receives U.S. FDA Accelerated Approval as A First-in-class PPAR Treatment for Primary Biliary Cholangitis
Ipsen Presents Long-term Elafibranor Efficacy and Itch-related Quality of Life Data in Patients with Primary Biliary Cholangitis
HUB Organoids B.V. Awarded Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Transforming Drug Development

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)